Clinical Trials Browser

Has results × Endometrial Adenocarcinoma × Taxes × Clear all

NCT00977574 2025-10-31

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Phase 2 Active not recruiting

349 enrolled 11 charts

GynecologicSarcoma

Endometrial Adenocarcinoma

NCT01041027 2023-10-26

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Phase 2 Terminated

31 enrolled 8 charts

Endometrial Adenocarcinoma

NCT00006011 2015-05-19

Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Phase 3 Completed

659 enrolled 8 charts

Endometrial Adenocarcinoma